Executive Director, Market Access
allogene
About this role
An Executive Director, Market Access at Allogene Therapeutics defines and leads global market access strategy for allogeneic CAR T therapies. This role focuses on pricing, payer engagement, reimbursement, and patient access while collaborating with cross-functional teams to shape value propositions and access strategies.
Skills
Qualifications
About allogene
allogene.comAllogene is a clinical-stage biotechnology company developing off-the-shelf AlloCAR T cell therapies using multiplex gene engineering and gene-editing to create allogeneic (ready-made) CAR T candidates. The company pairs a proprietary lymphodepletion approach with scalable, state-of-the-art manufacturing to optimize safety, durability, and broader patient access. Lead programs include cemacabtagene ansegedleucel (cema‑cel) for large B‑cell lymphoma (including frontline DLBCL), ALLO‑316 for renal cell carcinoma, and ALLO‑329 for autoimmune disease, alongside a broader pipeline. Allogene’s platform strategy aims to accelerate delivery of cell therapies by removing patient-specific manufacturing constraints.
About allogene
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Leadership Team
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
Unlock Company Insights
View leadership team, funding history,
and employee contacts for allogene.
Salary
$280k – $320k
per year
More jobs at allogene
Similar Jobs
Director, Global Market Access, Immunology
MSD
Director International Value & Access, NS
Diversity Employment
Associate Director Access & Reimbursement
CSL
Director International Value & Access, NS
Novartis
Senior Director, Market Access Strategy
Amylyx Pharmaceuticals
Director Global Market Access Oncology (Hematology)
MSD